Effect of asthma management with exhaled nitric oxideversususual care on perinatal outcomes
Open Access
- 17 November 2022
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 60 (5) , 2200298
Abstract
Introduction: Asthma exacerbations in pregnancy are associated with adverse perinatal outcomes. We aimed to determine whether fractional exhaled nitric oxide (FENO)-based asthma management improves perinatal outcomes compared to usual care.Methods: The Breathing for Life Trial was a multicentre, parallel-group, randomised controlled trial conducted in six hospital antenatal clinics, which compared asthma management guided byFENO(adjustment of asthma treatment according to exhaled nitric oxide and symptoms each 6–12 weeks) to usual care (no treatment adjustment as part of the trial). The primary outcome was a composite of adverse perinatal events (preterm birth, small for gestational age (SGA), perinatal mortality or neonatal hospitalisation) assessed using hospital records. Secondary outcomes included maternal asthma exacerbations. Concealed random allocation, stratified by study site and self-reported smoking status was used, with blinded outcome assessment and statistical analysis (intention to treat).Results: Pregnant women with current asthma were recruited; 599 to the control group (608 infants) and 601 to the intervention (615 infants). There were no significant group differences for the primary composite perinatal outcome (152 (25.6%) out of 594 control, 177 (29.4%) out of 603 intervention; OR 1.21, 95% CI 0.94–1.56; p=0.15), preterm birth (OR 1.14, 95% CI 0.78–1.68), SGA (OR 1.06, 95% CI 0.78–1.68), perinatal mortality (OR 3.62, 95% CI 0.80–16.5), neonatal hospitalisation (OR 1.24, 95% CI 0.89–1.72) or maternal asthma exacerbations requiring hospital admission or emergency department presentation (OR 1.19, 95% CI 0.69–2.05).Conclusion: FENO-guided asthma pharmacotherapy delivered by a nurse or midwife in the antenatal clinic setting did not improve perinatal outcomes.Keywords
Funding Information
- National Health and Medical Research Council (1060983, 1084816, 1155810)
- Hunter Medical Research Institute
- University of Newcastle Australia
- John Hunter Hospital Charitable Trust
This publication has 22 references indexed in Scilit:
- Interventions for managing asthma in pregnancyCochrane Database of Systematic Reviews, 2014
- Prenatal origins of bronchiolitis: protective effect of optimised asthma management during pregnancy: Table 1Thorax, 2013
- Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomesEuropean Respiratory Journal, 2012
- Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trialThe Lancet, 2011
- A meta-analysis of adverse perinatal outcomes in women with asthmaBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Medication use for chronic health conditions by pregnant women attending an Australian maternity hospitalAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2011
- The effect of cigarette smoking on asthma control during exacerbations in pregnant womenThorax, 2010
- Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control QuestionnaireRespiratory Medicine, 2006
- Asthma self-management skills and the use of asthma education during pregnancyEuropean Respiratory Journal, 2005
- Development and validation of a questionnaire to measure asthma controlEuropean Respiratory Journal, 1999